Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Impax Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Impax Labs Acquires Generic Products from Teva Pharma and Allergan for USD586 Million 13
Impax Labs Acquires Two Generic Products from Actavis 15
Amedra Pharmaceuticals Acquires Mebendazole Tablet Product from Teva Pharmaceutical 16
Partnerships 17
Impax Labs Enters Into Co-Development Agreement With Perrigo 17
Impax Labs Enters Into Development And Distribution Agreement With Tolmar 18
IMPAX Lab Enters Into Co-Development Agreement With TOLMAR 19
Merger 20
Amneal Merges with Impax 20
Licensing Agreements 22
Impax Labs Enters Into Licensing Agreement With Durect For Eladur 22
Impax Pharma Amends Licensing Agreement with AstraZeneca for Zomig 24
Debt Offering 26
Impax Labs Raises USD600 Million in Private Placement of 2% Notes Due 2022 26
Asset Transactions 28
ANI Pharma to Acquire Manufacturing Equipment from Amneal Pharma and Impax Labs 28
ANI Pharma to Acquire Generic Products from Amneal Pharma and Impax Labs 29
Bora Pharma to Acquire Manufacturing Facility from Impax Labs for USD18.5 Million 31
Turing Pharma Acquires Daraprim Marketing Rights in US from Impax Lab for USD55 Million 32
Acquisition 33
Impax Laboratories Sells CorePharma to Group Investors 33
Impax Acquires Lineage Therapeutics, Amedra Pharma and CorePharma for USD700 Million 34
Impax Laboratories Inc – Key Competitors 36
Impax Laboratories Inc – Key Employees 37
Impax Laboratories Inc – Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 40
Financial Announcements 40
Mar 01, 2018: Impax Reports Fourth Quarter and Full Year 2017 Results 40
Nov 09, 2017: Impax Reports Third Quarter 2017 Results 43
Aug 09, 2017: Impax Reports Solid Second Quarter 2017 Results with Total Revenues Increasing 17% to $202 Million 45
May 10, 2017: Impax Reports First Quarter 2017 Financial Results 47
Mar 01, 2017: Impax Reports Fourth Quarter and Full Year 2016 Financial Results 50
Corporate Communications 53
Nov 08, 2017: Impax Laboratories Mourns the Passing of Board Member Richard A. Bierly 53
Mar 27, 2017: Impax Board of Directors Appoints Paul M. Bisaro President and CEO 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55
Impax Laboratories Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Impax Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Impax Laboratories Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Impax Labs Acquires Generic Products from Teva Pharma and Allergan for USD586 Million 13
Impax Labs Acquires Two Generic Products from Actavis 15
Amedra Pharmaceuticals Acquires Mebendazole Tablet Product from Teva Pharmaceutical 16
Impax Labs Enters Into Co-Development Agreement With Perrigo 17
Impax Labs Enters Into Development And Distribution Agreement With Tolmar 18
IMPAX Lab Enters Into Co-Development Agreement With TOLMAR 19
Amneal Merges with Impax 20
Impax Labs Enters Into Licensing Agreement With Durect For Eladur 22
Impax Pharma Amends Licensing Agreement with AstraZeneca for Zomig 24
Impax Labs Raises USD600 Million in Private Placement of 2% Notes Due 2022 26
ANI Pharma to Acquire Manufacturing Equipment from Amneal Pharma and Impax Labs 28
ANI Pharma to Acquire Generic Products from Amneal Pharma and Impax Labs 29
Bora Pharma to Acquire Manufacturing Facility from Impax Labs for USD18.5 Million 31
Turing Pharma Acquires Daraprim Marketing Rights in US from Impax Lab for USD55 Million 32
Impax Laboratories Sells CorePharma to Group Investors 33
Impax Acquires Lineage Therapeutics, Amedra Pharma and CorePharma for USD700 Million 34
Impax Laboratories Inc, Key Competitors 36
Impax Laboratories Inc, Key Employees 37
Impax Laboratories Inc, Other Locations 38
Impax Laboratories Inc, Subsidiaries 38
List of Figures
Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
【免責事項】
http://www.globalresearch.jp/disclaimer